Myalgia Clinical Trial
Official title:
Comparative Evaluation of Continuous and Pulse Mode of Ultrasound Therapy in Myalgia of Maxillofacial Region
Pain and trismus caused by Myalgia in masticatory muscles are one of the prime concerns for the patients. Various studies have been performed using US therapy for myofascial pain syndrome of head & neck region. US is a non-invasive frequently used physical agent which increase blood flow in tissues and collagen fibers ability to grow, & reduce muscle spasm with its thermal effect. It is difficult to imply the results of studies performed in muscles of other regions of body to the maxillofacial region because of the superficial placement of these muscles.US is being frequently used for myofascial pain, but there is an absence of a consensus regarding the frequency and mode of administration available in literature for administration of this therapy in maxillofacial region. Therefore, the present study has been designed to compare the therapeutic effect of two modes of US i.e., continuous and pulsed at 3 MHz frequency
Pain and trismus caused by Myalgia in masticatory muscles are one of the prime concerns for the patients. There are limited number of studies in the literature that have evaluated therapeutic ultrasound for the management of Myalgia of maxillofacial region. Various studies have been performed, evaluating the treatment of myofascial pain with trigger point in other parts of body including neck region using ultrasound, but not all patient of myalgia present with trigger point. The most frequently used ultrasound frequencies are 1 and 3MHz. 1 MHz has more penetrating power as compared to 3MHz. Masticatory muscles being superficial in location need less penetrating waves as compared to other muscles. The ultrasound can be applied in a continuous or pulsed manner. There are studies supporting the fact that Continuous ultrasound therapy is more efficient in reducing myofascial pain syndrome of trapezius muscle at rest because it produces a heating effect in the muscles, that help in breaking the spasm. On the other hand, the pulsed mode, produces more of penetrating effect and acts on the gas bubbles of the soft tissues, thereby decreasing the inflammation. However, the two methods have not yet been compared in maxillofacial muscles. Therefore, this study aims to compare the outcome of therapeutic Ultrasound administered at 3MHz frequency in continuous & pulse modes in myalgia of maxillofacial region ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02362685 -
Metabolic Exercise Testing
|
||
| Recruiting |
NCT05033613 -
Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease
|
||
| Recruiting |
NCT03849534 -
Treatment of Temporomandibular Disorders in Children and Adolsecents
|
N/A | |
| Completed |
NCT04897581 -
BBTI vs PSR in Musculoskeletal Orofacial Pain Adults
|
N/A | |
| Completed |
NCT00957996 -
Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza
|
Phase 3 | |
| Completed |
NCT04581395 -
The Effect of Pretreatment With Roc on Succinylcholine Myalgias
|
Phase 3 | |
| Completed |
NCT01026311 -
Coenzyme Q10 in Older Athletes Treated With Statin Medications
|
Phase 4 | |
| Completed |
NCT01506583 -
Clinical Evaluation of QFlu Combo Test
|
||
| Completed |
NCT04797936 -
BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19
|
Phase 4 | |
| Terminated |
NCT02685202 -
Temporomandibular Disorder (TMD) Pain in Response to Jaw Advancement in People With TMD and Obstructive Sleep Apnea
|
N/A | |
| Completed |
NCT01279590 -
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
|
Phase 2 | |
| Recruiting |
NCT04806191 -
Simple and Evidence-based Examination and Treatment of Shoulder Pain in General Practice
|
N/A | |
| Not yet recruiting |
NCT01097798 -
To Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury.
|
Phase 3 | |
| Not yet recruiting |
NCT05961501 -
The Effectiveness of CBD and CBN in the Treatment of Facial Pain and Headache of Muscular Origin
|
Phase 2/Phase 3 | |
| Completed |
NCT05448209 -
The Effect of Walking Exercise Based on TOUS on Peripheral Neuropathy and Arthralgia-Myalgia in Women With Breast Cancer
|
N/A | |
| Not yet recruiting |
NCT03566394 -
Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT04426123 -
Masseter Myofascial Pain Relief Following an Intra-muscular Injection With Botulinum Toxin Type A.
|
Phase 2 | |
| Completed |
NCT04737278 -
Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06125002 -
Diosmin for Treatment of Delayed-onset Muscle Soreness (DOMS)
|
Phase 1 | |
| Completed |
NCT03371888 -
The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders
|
Phase 2/Phase 3 |